How many drugs treat Tuberculosis of meninges?

Drug Landscape tracks 1 marketed treatments for Tuberculosis of meninges (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/tuberculosis-of-meninges.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Tuberculosis of meninges — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tuberculosis of meninges (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Tuberculosis of meninges, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Pyrazinamide	PYRAZINAMIDE	Dava Pharms Inc	Antimycobacterial [EPC]	Cytochrome P450 3A4		1971-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Dava Pharms Inc · 1 drug in Tuberculosis of meninges

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Tuberculosis of meninges:

Cite this brief

Drug Landscape (2026). Tuberculosis of meninges — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/tuberculosis-of-meninges. Accessed 2026-06-10.

Tuberculosis of meninges full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing